Baker McKenzie BV/SRL’s multidisciplinary healthcare and life sciences group combines regulatory, antitrust and corporate finance expertise to advise pharmaceutical, biotech, medical device and healthcare clients. Co-head Els Janssens provides strategic regulatory and policy advice, Roel Meers brings extensive transactional experience in the Benelux bio and health tech markets, and Fiona Carlin advises leading pharmaceutical companies on European distribution structures and competition issues.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- 'Els Janssens consistently functions as an invaluable thought partner. Her counsel extends beyond standard legal review; she proactively engages in strategic discussions, offering insightful perspectives that shape business approaches and lead to optimal, legally sound solutions. Her ability to integrate legal expertise with business objectives makes her contribution indispensable.'
- 'Els Janssens is recognised as an exemplary and highly effective Legal Counsel. Her commitment to being always reachable is a critical asset to the organisation, particularly when time-sensitive and complex legal matters arise. This unwavering accessibility ensures that strategic decisions can be made swiftly and with comprehensive legal clarity, significantly mitigating risk.'
Key clients
- Abbott
- Abbvie
- Acino
- Advanced Instruments
- Agomab Therapeutics
- Alcon
- Align Technology
- Almirall
- Ansell
- Astellas
- Astra Zeneca
- Baxter
Work highlights
Advised on developing an application to streamline sponsorship of healthcare and veterinary professionals at scientific and commercial events, translating complex EU and Belgian compliance rules into practical approval thresholds. The project included analysing veterinary sector rules and supporting future industry advocacy, and was delivered with German colleagues in a cross-border context, with Belgium as the pilot market.
Advised Sequana Medical on a series of complex financing transactions totalling over €10 million, including convertible bridge loans, credit facility restructurings, and a €3 million loan with deferred debt service.
Represented multiple Menarini Group entities in international litigation against Dishman Carbogen Amcis Ltd, an India-based pharmaceutical and chemical manufacturer. The dispute concerns the manufacture and supply of chemical components and active pharmaceutical ingredients.
Lawyers
Leading associates
Leading associates with regular involvement in their team's key work, and recognition from peers or clients as being ones to watch.
Practice head
Els Janssens; Roel Meers; Fiona Carlin
Other key lawyers
Elisabeth Dehareng; Gregory Lebrun